Chargement en cours...
Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
BACKGROUND: The calcineurin (CaN) inhibitor, tacrolimus, is widely used in patients undergoing allogeneic organ transplantation and in those with certain allergic diseases. Recently, several reports have suggested that CaN is also associated with schizophrenia. However, little data are currently ava...
Enregistré dans:
| Publié dans: | Neuropsychiatr Dis Treat |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4940021/ https://ncbi.nlm.nih.gov/pubmed/27462157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S106371 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|